Last Updated: November 8, 2026

Details for Patent: 3,806,534

Name: Drug Patent Intelligence for US Patent 3806534
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

Summary for Patent: 3,806,534

Title:	Sulphamyl-benzoic acid derivatives
Abstract:	THIS INVENTION RELATES TO NEW, THERAPEUTICALLY ACTIVE COMPOUNDS OF THE GENERAL FORMULA 1-(R4-N(-R5)-),2-A,3-(R3-N(-R6)-SO2-),5-(HOOC-)BENZENE IN WHICH A REPRESENTS ONE OF THEGROUPINGS R1-N(-R2)-, R2-O-, R2-S-, R2-OS, AND R2-O2S-, R1, R2, R3, AND R4 EACH REPRESENTS HYDROGEN, AN ALIPHATIC RADICAL, A CYCLOALIPHATIC RADICAL, OR AN AROMATICALLY, CYCLOALIPHATICALLY, OR HETEROCYCLICALLY SUBSTITUTED ALIPHATIC RADICAL, IN ADDITION TO WHICH R2 AND R3 MAY EACH REPRESENT AN AROMATIC OR HETEROCYCLIC RADICAL, AND WHEN A IS R1-N(-R2)-, R1 AND R2 MAY IRON PENTACARBONYL TOGETHER WITH THE DIENE IN A SOLVENT AT TEMPERATURES WITHIN THE RANGE TROGEN ATOMS, SULPHUR ATOMS, OR OXYGEN ATOMS IN ADDITION TO THE NITROGEN ATOM LINKED TO R1 AND R2; R5 IS HYDROGEN OR LOWER ALKYL; AND R6 IS HYDROGEN OR LOWER ALKYL OR ACYL; TO SALTS, ESTERS, AND AMIDES OF THE SAID COMPOUNDS; AND TO METHODS FOR THE PRODUCTION OF THE COMPOUNDS.
Inventor(s):	P Feit
Assignee:	Leo Pharma AS
Application Number:	US00887409A
Patent Claim Types: see list of patent claims

Drugs Protected by US Patent 3,806,534

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 3,806,534

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	308069	⤷ Start Trial
Belgium	743744	⤷ Start Trial
Bulgaria	17812	⤷ Start Trial
Brazil	6915200	⤷ Start Trial
Switzerland	532559	⤷ Start Trial
Cyprus	697	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.